Pharmidex

We're having a great day at #genesis2024 in London. Pitched up with Ash Alavijeh from Pharmidex we've been discussing in Vivo- in vitro translation in NGRA approaches.

Pharmidex is honored to attend the Society for Medicines Research meeting: "Recent Trends in Medicinal Chemistry and Enabling Technologies" 📅 Thursday, 5 December 2024 📍 Burlington House, Piccadilly, London, W1J 0BQ, UK 👉 https://lnkd.in/gi3anrpG We are excited to share that our Business Development Manager, Janette Dalay Robertson, will represent Pharmidex at this prestigious event. Janette looks forward to engaging with attendees to explore and foster commercial synergies, advancing shared goals and collaboration between your companies, institutions, and Pharmidex. If you're attending, be sure to connect with Janette for a discussion about how we can work together to achieve innovative breakthroughs! 🌟 #Pharmidex #MedicinalChemistry #Collaboration #Innovation #Chemistry #Chemicalbiology #Medicinesresearch #Peptides #Oligonucleotides #Drugdiscovery #AI #TPD #RoyalSocietyofChemistry  

Pharmidex is thrilled to announce that Ash Alavijeh, our Head of Operations, will attend the "Maximising Returns from Life Science Innovation" conference by One Nucleus on 4 December 2024, at 1 Wimpole Street, London, UK (https://lnkd.in/ea5abEEQ). This dynamic event is a fantastic opportunity to explore life science breakthroughs and connect with industry leaders. Ash is excited to meet attendees, exchange ideas, and discuss ways to innovate together. Don’t miss the chance to say hello! #Pharmidex #LifeScienceInnovation #Networking #GenesisConference

LinkedIn Announcement: Pharmidex is excited to share that our Head of Oncology, Dr. Christopher Ireson, will be attending the DRUG DISCOVERY Paris: SINGLE CELL GENOMICS forum on 3 December 2024! 🎉 This event, organized by ELRIG UK (https://lnkd.in/enEA8GuS), brings together thought leaders in drug discovery and genomics, focusing on the latest advancements in single-cell technologies. Dr. Ireson is eager to connect with fellow attendees to discuss cutting-edge research and explore potential collaborations. If you’re attending, he’d be delighted to meet with you, don’t hesitate to reach out or catch him at the event! #Pharmidex #DrugDiscovery #SingleCellGenomics #OncologyResearch

🌟 Pharmidex at Cambridge New Therapeutics Forum (CamNTF)! 🌟 We’re excited to share that Ash Alavijeh, our Head of Operations, will attend the Cambridge New Therapeutics Forum (CamNTF) on Tuesday, 3rd December 2024, from 17:30 to 20:00 at the Cancer Research UK Cambridge Institute, Cambridge CB2 0RE. Ash looks forward to meeting attendees, exchanging ideas, and exploring collaboration opportunities. Don’t hesitate to say hello and share your exciting projects! 🎟️ Learn more: CamNTF (Cambridge New Therapeutics Forum Tickets, Tue, Dec 3, 2024 at 5:30 PM | Eventbrite) #Pharmidex #CamNTF #Innovation #Networking

SBC were delighted to take part in Life Science Integrates #ATI2024, held at GSK’s #Stevenage Campus today.   Over 100 attendees from the #advanced #therapies industry gathered together across a series of seminars, panels and fireside chats to examine challenges and opportunities related to topics such as #funding, #skills and #commercialisation.   SBC’s Business Development and #Entrepreneurship Director Marco Delise, PhD joined the panel ‘#Hub-ble Bubble’ to discuss the importance of #innovation hubs and the advantages of SBC being exclusively focused on #medical R&D. SBC has had four cell and gene therapy exits in the past seven years (3 IPOS and 1 M&A) including Autolus Therapeutics, whose CAR T cell therapy recently obtained FDA approval in the USA.   Marco discussed SBC’s threefold approach to supporting the ecosystem with:   🌟 #Facilities – free shared equipment is available for all start-ups to use, including specialist flow cytometry, with training provided 🌟 #Community –  a collaborative environment with over 30 annual networking events, including CEO roundtables, to share expertise and contacts 🌟 #OpenInnovation – connecting the external #ecosystem, such as #investors and related #workshops, with the campus community to help refine business skills   SBC-based occupiers also joined a wide range of panels: MFX’s Antoine Espinet and Achilles Therapeutics plc's Katy Newton were on the session ‘A Digital Revolution & A Person-Centric Approach’ and how the #UK is embracing new opportunities to make #ATMPs faster, taking into account efficiency, quality control and sustainability. Cell and Gene Therapy Catapult’s Ian M. Parnham, PhD joined MFX’s James Kusena PhD, Complement Therapeutics' Mustafa Munye, Cytiva’s Dharmesh Vara and LifeArc’s Anji Miller Ph.D CLP RTTP for the panel on ‘It’s an upskill battle’ to discuss the importance of constantly evolving #skills and how industry and government can work together to ensure the UK has the skilled workforce needed for the growth of the ATMP sector. Thank you Life Science Integrates for a great event with many networking opportunities, we look forward to the next one! #cellandgene #lifesciences #sciencepark #healthinnovation #stevenage Dr Sally Ann Forsyth OBE Oliver King Sureyya Hilmi

Pharmidex had an incredible time at Advanced Therapies Integrates 2024! 🎉 Ash Alavijeh and Janette Dalay Robertson, were thrilled to attend the dynamic and insightful conference. The sessions were packed with thought-provoking discussions. Special thanks to the organisers at Life Science Integrates, Cell and Gene Therapy Catapult and GSK for creating such a fantastic space to connect and share ideas. Oh, and a fun side note: Janette Dalay Robertson might have spent a bit too much time experimenting with the Virtual Reality glasses! 🕶️ Let’s just say She's ready for the metaverse now. 😉 Looking forward to continuing the conversations we started and exploring potential collaborations with some of the amazing people we met! #AdvancedTherapiesIntegrates #Networking #Innovation #Pharmidex #catapultcellandgenetherapy #GSK

🌟 Pharmidex Announcement 🌟 We’re excited to share that Ash Alavijeh, our Head of Operations, and Janette Dalay Robertson, our Business Development Manager, will represent Pharmidex at Advanced Therapies Integrates 2024, uniting industry leaders to explore advanced therapies. 📅 Date: 26th November 2024 📍 Venue: GSK, Stevenage Both of them will be eager to connect, share insights and discuss the latest in advanced therapies with professionals shaping the future of life sciences. Don’t miss the chance to meet them at the event! #Pharmidex #AdvancedTherapies #LifeSciences #Innovation #Networking

🌟 Pharmidex Announcement 🌟 We are delighted to announce that Ian Knowles, our Head of Respiratory, will represent Pharmidex at the 7th Annual Inhalation & Respiratory Drug Delivery Conference and Christmas Industry Celebration! 🎄💨 📅 Dates: November 21-22, 2024 📍 Venue: Occidental Praha, Prague, Czechia Ian is looking forward to engaging with all attendees, sharing insights, and exploring the latest innovations in respiratory and inhalation drug delivery. Events like these are a fantastic opportunity to foster collaboration, advance research, and shape the future of respiratory medicine. If you’re attending, be sure to connect with Ian at the event, he’d be thrilled to meet and discuss ideas with you! #Pharmidex #RespiratoryMedicine #InhalationTherapies #DrugDelivery #Innovation #Networking #PharmaEvents

It was a pleasure for SBC to attend ‘The quest for new medicines to slow the progression of disability in neurodegenerative disorders’ conference hosted in collaboration with the Society for Medicines Research and the British Neuroscience Association at AstraZeneca’s #Biomedical Campus in #Cambridge with SBC-based business Pharmidex.   Pharmidex's MD Prof Mo Alavijeh, chaired Session 2, part 1, on Neuroprotective strategies for #Parkinson’s disease led by Dr Jonathan Brotchie, Chairman and Co-Founder of Atuka Inc. and Session 2, part 2, on Targeting alpha-synuclein: the MEDI1341/TAK-341 program led by Dr Kirsten Scott, Medical Director, #Neuroscience, R&D #BioPharmaceuticals, #AstraZeneca.   An awe inspiring day with seminars on next generation medicine being developed across the #UK to treat wide ranging #CNS diseases from #Stroke, #MND and #ALS through to #Alzheimer's, #Parkinson’s, and #Huntington’s Disease. #NeurodegenerativeResearch #DrugDiscovery #SMRMeeting #Collaboration Dr Sally Ann Forsyth OBE Jewel Ahmed Janette Dalay Robertson Ash Alavijeh Marco Delise, PhD Sureyya Hilmi Stephen Mitchell